Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Galecto, Inc. (GLTO) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Galecto, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1800315.
Total stock buying since 2020: $28,139,829.
Total stock sales since 2020: $1,697,026.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 3,215 | $15,478 | 7,100 | $0 |
| 2023 | 0 | $0 | 681,948 | $1,681,548 | 0 | $0 |
| 2022 | 19,604 | $42,294 | 0 | $0 | 0 | $0 |
| 2021 | 25,500 | $97,560 | 0 | $0 | 0 | $0 |
| 2020 | 1,866,665 | $27,999,975 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 1,142 | $3,863 | 2,414 | $0 |
| 2025-01 | 0 | $0 | 2,073 | $11,615 | 4,686 | $0 |
| 2023-07 | 0 | $0 | 443,300 | $1,209,944 | 0 | $0 |
| 2023-04 | 0 | $0 | 238,648 | $471,604 | 0 | $0 |
| 2022-03 | 19,604 | $42,294 | 0 | $0 | 0 | $0 |
| 2021-12 | 6,000 | $14,920 | 0 | $0 | 0 | $0 |
| 2021-11 | 7,500 | $25,950 | 0 | $0 | 0 | $0 |
| 2021-08 | 3,000 | $11,760 | 0 | $0 | 0 | $0 |
| 2021-06 | 9,000 | $44,930 | 0 | $0 | 0 | $0 |
| 2020-11 | 1,866,665 | $27,999,975 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-03 | Schambye Hans T. (Chief Executive Officer) | Sale | 735 | 3.38 | 2,484 |
| 2025-07-03 | Schambye Hans T. (Chief Executive Officer) | Option Ex | 1,360 | .00 | 0 |
| 2025-07-03 | Firmani Lori (Interim CFO) | Sale | 147 | 3.39 | 498 |
| 2025-07-03 | Firmani Lori (Interim CFO) | Option Ex | 374 | .00 | 0 |
| 2025-07-03 | Winslow Garrett (General Counsel) | Sale | 260 | 3.39 | 881 |
| 2025-07-03 | Winslow Garrett (General Counsel) | Option Ex | 680 | .00 | 0 |
| 2025-01-03 | Schambye Hans T. (Chief Executive Officer) | Sale | 1,341 | 5.60 | 7,509 |
| 2025-01-03 | Schambye Hans T. (Chief Executive Officer) | Option Ex | 2,640 | .00 | 0 |
| 2025-01-03 | Firmani Lori (Interim CFO) | Sale | 261 | 5.63 | 1,469 |
| 2025-01-03 | Firmani Lori (Interim CFO) | Option Ex | 726 | .00 | 0 |
| 2025-01-03 | Winslow Garrett (General Counsel) | Sale | 471 | 5.60 | 2,637 |
| 2025-01-03 | Winslow Garrett (General Counsel) | Option Ex | 1,320 | .00 | 0 |
| 2023-07-31 | Orbimed Capital Gp Vii Llc | Sale | 209,400 | 3.00 | 628,200 |
| 2023-07-25 | Orbimed Capital Gp Vii Llc | Sale | 39,200 | 2.92 | 114,464 |
| 2023-07-13 | Orbimed Capital Gp Vii Llc | Sale | 194,700 | 2.40 | 467,280 |
| 2023-04-17 | Orbimed Capital Gp Vii Llc | Sale | 13,089 | 1.97 | 25,785 |
| 2023-04-14 | Orbimed Capital Gp Vii Llc | Sale | 41,446 | 1.86 | 77,089 |
| 2023-04-13 | Orbimed Capital Gp Vii Llc | Sale | 13,946 | 1.82 | 25,381 |
| 2023-04-12 | Orbimed Capital Gp Vii Llc | Sale | 2,363 | 1.81 | 4,277 |
| 2023-04-11 | Orbimed Capital Gp Vii Llc | Sale | 13,946 | 1.82 | 25,381 |
| 2023-04-10 | Orbimed Capital Gp Vii Llc | Sale | 51,228 | 1.79 | 91,698 |
| 2023-04-06 | Orbimed Capital Gp Vii Llc | Sale | 9,665 | 2.00 | 19,330 |
| 2023-04-05 | Orbimed Capital Gp Vii Llc | Sale | 92,965 | 2.18 | 202,663 |
| 2022-03-22 | Lindmark Bertil (Chief Medical Officer) | Buy | 14,604 | 2.16 | 31,544 |
| 2022-03-22 | Schambye Hans T. (Chief Executive Officer) | Buy | 5,000 | 2.15 | 10,750 |
| 2021-12-03 | Winslow Garrett (General Counsel) | Buy | 2,000 | 2.48 | 4,960 |
| 2021-12-03 | Freve Jonathan (Chief Financial Officer) | Buy | 4,000 | 2.49 | 9,960 |
| 2021-11-09 | Schambye Hans T. (Chief Executive Officer) | Buy | 4,500 | 3.50 | 15,750 |
| 2021-11-08 | Freve Jonathan (Chief Financial Officer) | Buy | 3,000 | 3.40 | 10,200 |
| 2021-08-18 | Freve Jonathan (Chief Financial Officer) | Buy | 3,000 | 3.92 | 11,760 |
| 2021-06-28 | Lindmark Bertil (Chief Medical Officer) | Buy | 2,000 | 5.26 | 10,520 |
| 2021-06-24 | Schambye Hans T. (Chief Executive Officer) | Buy | 3,000 | 5.11 | 15,330 |
| 2021-06-23 | Winslow Garrett (General Counsel) | Buy | 2,000 | 4.80 | 9,600 |
| 2021-06-23 | Freve Jonathan (Chief Financial Officer) | Buy | 2,000 | 4.74 | 9,480 |
| 2020-11-02 | Orbimed Genesis Gp Llc (Director) | Buy | 733,333 | 15.00 | 10,999,995 |
| 2020-11-02 | Khuong Chau Quang (Director) | Buy | 733,333 | 15.00 | 10,999,995 |
| 2020-11-02 | Novo Holdings A/s (10% Owner) | Buy | 333,333 | 15.00 | 4,999,995 |
| 2020-11-02 | Christgau Stephan (Director) | Buy | 66,666 | 15.00 | 999,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of GLTO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Galecto, Inc. (symbol GLTO, CIK number 1800315) see the Securities and Exchange Commission (SEC) website.